{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intravenous+linezolid", "query": { "intervention": "Intravenous linezolid" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 15, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intravenous+linezolid&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-19T13:48:42.751Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00035425", "title": "Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Febrile Neutropenia" ], "interventions": [ { "name": "linezolid", "type": "DRUG" }, { "name": "vancomycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 120, "start_date": "2001-11", "completion_date": "2002-11", "has_results": false, "last_update_posted_date": "2009-12-01", "last_synced_at": "2026-09-19T13:48:42.751Z", "location_count": 16, "location_summary": "Los Angeles, California • Springfield, Illinois • The Bronx, New York + 5 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Springfield", "state": "Illinois" }, { "city": "Springfield", "state": "Illinois" }, { "city": "Springfield", "state": "Illinois" }, { "city": "Springfield", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00035425" }, { "nct_id": "NCT00084266", "title": "Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Methicillin Resistant Staphylococcus Aureus (MRSA)" ], "interventions": [ { "name": "linezolid (Zyvox)", "type": "DRUG" }, { "name": "vancomycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1225, "start_date": "2004-10", "completion_date": "2010-03", "has_results": true, "last_update_posted_date": "2012-02-01", "last_synced_at": "2026-09-19T13:48:42.751Z", "location_count": 108, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Montgomery, Alabama + 71 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00084266" }, { "nct_id": "NCT00299520", "title": "Phase 3 Safety and Efficacy Study of I.V. Iclaprim v Linezolid in cSSSI (ASSIST-1)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Complicated Skin and Skin Structure Infection" ], "interventions": [ { "name": "intravenous iclaprim or intravenous linezolid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Arpida AG", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": "2005-06", "completion_date": "2006-07", "has_results": false, "last_update_posted_date": "2008-04-04", "last_synced_at": "2026-09-19T13:48:42.751Z", "location_count": 5, "location_summary": "National City, California • Boise, Idaho • Indianapolis, Indiana + 2 more", "locations": [ { "city": "National City", "state": "California" }, { "city": "Boise", "state": "Idaho" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Cumberland", "state": "Maryland" }, { "city": "Toledo", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00299520" }, { "nct_id": "NCT02426918", "title": "Study of Debio 1450 for Bacterial Skin Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bacterial Infections" ], "interventions": [ { "name": "Debio 1450 IV", "type": "DRUG" }, { "name": "Debio 1450 Oral", "type": "DRUG" }, { "name": "Linezolid", "type": "DRUG" }, { "name": "Debio 1450 Oral Placebo", "type": "DRUG" }, { "name": "Linezolid Placebo", "type": "DRUG" }, { "name": "Vancomycin IV", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Debiopharm International SA", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 330, "start_date": "2015-05", "completion_date": "2016-09", "has_results": true, "last_update_posted_date": "2019-11-13", "last_synced_at": "2026-09-19T13:48:42.751Z", "location_count": 22, "location_summary": "Anaheim, California • Buena Park, California • Chula Vista, California + 17 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Anaheim", "state": "California" }, { "city": "Buena Park", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "La Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02426918" }, { "nct_id": "NCT02559310", "title": "Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Community Acquired Pneumonia" ], "interventions": [ { "name": "lefamulin", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Linezolid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nabriva Therapeutics AG", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 551, "start_date": "2015-09", "completion_date": "2017-05", "has_results": true, "last_update_posted_date": "2019-10-23", "last_synced_at": "2026-09-19T13:48:42.751Z", "location_count": 7, "location_summary": "Hazard, Kentucky • Shreveport, Louisiana • Minneapolis, Minnesota + 4 more", "locations": [ { "city": "Hazard", "state": "Kentucky" }, { "city": "Shreveport", "state": "Louisiana" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Butte", "state": "Montana" }, { "city": "Akron", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02559310" }, { "nct_id": "NCT00633152", "title": "Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bacterial Infection" ], "interventions": [ { "name": "ceftaroline", "type": "DRUG" }, { "name": "linezolid", "type": "DRUG" }, { "name": "Aztreonam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2008-02", "completion_date": "2008-07", "has_results": true, "last_update_posted_date": "2017-03-14", "last_synced_at": "2026-09-19T13:48:42.751Z", "location_count": 13, "location_summary": "Buena Park, California • Long Beach, California • Los Angeles, California + 10 more", "locations": [ { "city": "Buena Park", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Rolling Hills Estate", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00633152" }, { "nct_id": "NCT02732327", "title": "Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Neoplasms", "Febrile Neutropenia" ], "interventions": [ { "name": "CAZ-AVI", "type": "DRUG" }, { "name": "Vancomycin", "type": "DRUG" }, { "name": "Linezolid", "type": "DRUG" }, { "name": "Cefepime", "type": "DRUG" }, { "name": "Meropenem", "type": "DRUG" }, { "name": "Piperacillin/tazobactam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2, "start_date": "2016-05-17", "completion_date": "2016-06-27", "has_results": true, "last_update_posted_date": "2017-07-21", "last_synced_at": "2026-09-19T13:48:42.751Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02732327" }, { "nct_id": "NCT05977868", "title": "Comparing Oral Versus Parenteral Antimicrobial Therapy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Endovascular Infection", "Bone and Joint Infection", "Skin and Soft Tissue Infection", "Pulmonary Infection", "Gastrointestinal Infection", "Genitourinary Infection" ], "interventions": [ { "name": "Amoxicillin, amoxicillin-clavulanate, cefadroxil, cefpodoxime, cefalexin, ciprofloxacin, delafloxacin, doxycycline, levofloxacin, linezolid", "type": "DRUG" }, { "name": "Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "West Virginia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 94, "start_date": "2023-08-04", "completion_date": "2025-02-14", "has_results": true, "last_update_posted_date": "2025-08-26", "last_synced_at": "2026-09-19T13:48:42.751Z", "location_count": 1, "location_summary": "Morgantown, West Virginia", "locations": [ { "city": "Morgantown", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05977868" }, { "nct_id": "NCT02679573", "title": "Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Community Acquired Bacterial Pneumonia" ], "interventions": [ { "name": "Delafloxacin", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Linezolid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Melinta Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 860, "start_date": "2016-12-14", "completion_date": "2018-08-07", "has_results": true, "last_update_posted_date": "2020-02-27", "last_synced_at": "2026-09-19T13:48:42.751Z", "location_count": 25, "location_summary": "Montgomery, Alabama • Newark, Delaware • Coral Gables, Florida + 21 more", "locations": [ { "city": "Montgomery", "state": "Alabama" }, { "city": "Newark", "state": "Delaware" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "DeBary", "state": "Florida" }, { "city": "DeLand", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02679573" }, { "nct_id": "NCT02066402", "title": "Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bacterial Infections" ], "interventions": [ { "name": "Tedizolid (BAY119-2631)", "type": "DRUG" }, { "name": "Placebo Tedizolid (BAY119-2631)", "type": "DRUG" }, { "name": "Linezolid", "type": "DRUG" }, { "name": "Placebo Linezolid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 598, "start_date": "2014-03-04", "completion_date": "2016-04-18", "has_results": true, "last_update_posted_date": "2017-06-07", "last_synced_at": "2026-09-19T13:48:42.751Z", "location_count": 5, "location_summary": "Chula Vista, California • La Mesa, California • Oceanside, California + 2 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Las Vegas", "state": "Nevada" }, { "city": "Teaneck", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02066402" } ] }